Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Neuropharmacology. 2011 May 5;61(4):558–564. doi: 10.1016/j.neuropharm.2011.04.026

Table 2.

Percentages of Fos-labeled neurons co-labeled for BDNF, and FG-labeled neurons co-labeled for Fos in SAL, ACU, and REP groups.

Percent of Fos-labeled neurons with BDNF labeling
ACG PRL IL VTA
SAL 13.6 ± 3.2 14.3 ± 3.0 12.8 ± 3.2 2.4 ± 2.4
ACU 23.1 ± 1.8 21.3 ± 1.4 19.3 ± 1.3 14.7* ± 1.7
REP 26.5* ± 2.7 33.2*# ± 2.2 33.3*# ± 1.3 37.8*# ± 2.0
Percent of FG-labeled neurons with Fos labeling
ACG PRL IL
SAL 24.1 ± 4.0 22.5 ± 5.0 18.6 ± 3.4
ACU 48.5* ± 6.3 39.5* ± 2.8 39.3* ± 6.3
REP 62.6* ± 4.7 49.2* ± 4.5 52.3* ± 5.0
*

p ≤ 0.05 vs. SAL;

#

p ≤ 0.05 vs. ACU.